05.04.26 -- STREAM Edition: The Reality Of AI In Clinical Supplies

Accelerate your therapeutic antibody and complex protein development with advanced mammalian cell line platforms that move from DNA to RCB in just 10 weeks.

Tom Sellig, CEO, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

Explore real examples of how this outsourcing partner helps drug sponsors through transparency that empowers, integration that simplifies, methods that de-risk, and experience that accelerates.

This segment of the Outsourced Pharma Live event, "Clinical Supply Therapy: Lowering Risk and Your Blood Pressure," addresses the current impact and future potential of artificial intelligence in the clinical supply chain. 

Designed for medium‑ to high‑volume ISO syringes and cartridges, this high‑speed filling line delivers tight manufacturing control, supports larger batches, and meets growing biologics demand.

See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.